$TNRG #stocktowatch Use of Santilli Magnecules to Clean

New Post Public Reply Private Reply Replies (0) Message Board
chicagopixels
125
$TNRG #stocktowatch Use of Santilli Magnecules to Clean Fossil Fuel Combustion

TARPON SPRINGS, FL / ACCESSWIRE / September 18, 2018 / Adcents has become aware of important developments by Dr. R.M. Santilli as Chief Scientist of the publicly traded company Thunder Energies Corporation (OTCQB: TNRG) for the clean combustion of fossil fuels permitted by his new chemical species of magnecules, which has recently received the U. S. Patent Number 9,700,870, B2 under the title “Method and Apparatus for the industrial production of new hydrogen-rich fuels United States.”

A primary reason for our environmental problems is that the current combustion of fossil fuels, such as gasoline, diesel or coal, is incomplete since about 30% of the original fuel is released unburned in the environment. But the contaminants released in the exhaust, such as Carbon Monoxide CO, HydroCarbons HC and others are combustible. This is clear evidence that their lack of combustion is due to insufficient flame temperature, the strength of the valence bond of fossil fuel, and other factors.
Magnecules

The new chemical species of Santilli Magnecules, first introduced in the monograph Foundations of Hadronic Chemistry, consist of: Individual atoms H, C, O, etc., dimers CH, OH, etc., and conventional molecules H2, CO, etc., bonded together by opposing polarities of the polarization of the orbits of peripheral atomic electrons into toroids achieved via intense electric and magnetic fields.

The first feature of Santilli magnecules which is important for environmental problems is that their bond is much weaker than the valence bond of molecules, which is a necessary condition to achieve full combustion. A second important feature is that the magnecular bond disappears at the combustion temperature, as it is typically the case for all magnetic bonds, thus allowing the combustion among free atoms, rather than among molecules. The third feature is that, in view of the preceding two features, the combustion temperature of fuels with Santilli magnecular structure is much higher than the flame temperature of fuels with conventional molecular structure.

These features have been industrially established by Dr. Santilli with the new fuel MagneGas which he developed from 2004 to 2012 when he was Chief Scientist of the U. S. publicly traded company Magnegas Corporation. In fact, according to independent certifications by Atlantic Analytic Laboratory and other laboratories, magnegas has no CO and no HC in the combustion exhaust. Additionally, magnegas has a flame temperature of about 10,500 F which is almost triple the combustion temperature of fossil fuels, as certified by the CCNY measurements of the anomalous flame temperature of magnegas. In the indicated new capacity as Chief Scientist of Thunder Energies Corporation, Dr. Santilli is extending to fossil fuels the full combustion already achieved with magnegas via the basically novel HyperCombustion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 3

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Big Screen Entertainment Group Unveils Big Screen Capital Fund

Updated Category News Views 138

Introducing Big Screen Capital Big Screen Entertainment Group (OTC:BSEG) has just announced the launch of its new funding subsidiary, Big Screen Capital. This exciting development is set to finance a range of creative projects, including the establishment of the Big Film Fund, as well as two upcoming films and advancements in medical technology. With this strategic move,...

Continue Reading
Air Products Faces Integrity Challenges: A Call for Change

Updated Category News Views 129

Understanding the Recent Calls for Change at Air Products Mantle Ridge has taken a bold step by issuing a shareholder letter that highlights critical concerns regarding Air Products and Chemicals, Inc. The organization, which owns approximately $1.3 billion in shares of Air Products, has pointed out various omissions and misleading statements from the company’s...

Continue Reading
Navigating Key Market Shifts in H2 2026: A Crucial Period

Updated Category News Views 5

The Intensity of Mid-2026: Traders Brace for Impact Traders are steeling themselves for July's rollercoaster of central bank decisions. This isn't just another season; it's a potential market earthquake. When you've got the European Central Bank, Bank of England, and Federal Reserve all signaling rate announcements within days, it's time to pay more than a little...

Continue Reading
Summary of Recent Extraordinary General Meeting Outcomes

Updated Category News Views 158

Results of Extraordinary General Meeting Announcement German High Street Properties A/S is pleased to present the results from the extraordinary general meeting that took place. This meeting marks a significant moment for the company and its shareholders as they come together to discuss essential matters affecting the company's future. Date and Purpose of the Meeting The...

Continue Reading
Tectonic Therapeutics Advances TX45 for Heart Failure Treatment

Updated Category News Views 166

Tectonic Therapeutics Advances TX45 for Heart Health Tectonic Therapeutic, Inc. (NASDAQ: TECX), an innovative biotechnology company, has announced promising outcomes from its Phase 1a trials, which could lead to significant progress in treating Group 2 Pulmonary Hypertension in patients experiencing Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The results...

Continue Reading